临床采血管种类你分清楚了么?

2016-03-04 MedSci整理 燃点的博客

临床采血管那么多,你真的分得清么?真空采头盖和标签颜色不同代表采血管内添加剂种类和试验用途不同。医务人员可以根据体检项目或实验指标的相关要求选择相应的试管。目前临床上常见的真空采血管一般分为以下几种: 1.普通血清管(红色头盖),采血管内不含任何添加剂,一般10分钟左右使血液凝固,主要用于常规血清生化检验。 2.快速促凝血清管(橘红色头盖),采血管内含有促凝剂,激活纤维蛋白酶,使可溶性纤维

临床采血管种类那么多,你真的分得清么?真空采头盖和标签颜色不同代表采血管内添加剂种类和试验用途不同。医务人员可以根据体检项目或实验指标的相关要求选择相应的试管。目前临床上常见的真空采血管一般分为以下几种:

1.普通血清管(红色头盖),采血管内不含任何添加剂,一般10分钟左右使血液凝固,主要用于常规血清生化检验。常见的有血液中的细胞成分,包括红细胞、红细胞内的血红蛋白、白细胞、血小板四大类,共有20多项指标。

2.快速促凝血清管(橘红色头盖),采血管内含有促凝剂,激活纤维蛋白酶,使可溶性纤维蛋白变为不可溶的纤维蛋白多聚体,进而形成稳定的纤维蛋白凝块。一般5分钟内使血液凝固,主要用于急诊血清生化试检验。

3.惰性分离胶促凝管(金黄色盖),采血管内含有惰性分离胶和促凝剂。分离胶管具有很好的亲和性,起到隔离作用,标本离心后,分离胶能将血液中的液体成分(血清)和固体成分(血细胞)彻底分开并积聚在试管中形成屏障。血清冷藏状态下标本保持48小时内稳定。主要用于血清生化(肝功、肾功、心肌酶、淀粉酶等)、电解质(血清钾、钠、氯、钙、磷等)、甲状腺功能、药物检测、艾滋病检测、肿瘤标志物、PCR、TORCH、血清免疫学检测,用ELISA试剂盒检测各种炎性因子(IL-2、IL-6、TNF-a等)。

4.枸橼酸钠血沉试验管(黑色头盖),血沉试验要求的枸橼酸钠浓度是3.2%(相当于0.109mol/L),抗凝剂与血液的比例为1:4,一般抗凝剂比例过于偏高时,血液被稀释,可使血沉加快。采血时应注意采足血量(2ml),采血后应立即颠倒混匀8-10次,以保证检验结果的准确性。

5.枸橼酸钠凝血试验管(浅蓝色头盖),采血管内柠檬酸钠与血样中钙离子鳌合而起抗凝作用,抗凝剂与血比例为1:9,推荐的抗凝剂浓度是3.8%(相当于0.129mol/L),主要用于纤溶系统(凝血酶原时间、凝血酶时间、活化部分凝血酶时间、纤维蛋白原)。采血时应注意采足血量(2ml),采血后应立即颠倒混匀8-10次,以保证检验结果的准确性。

6.肝素抗凝管(绿色头盖),采血管含有肝素。肝素具有直接抗凝血酶的作用,可延长标本凝血时间。主要适用于红细胞脆性试验,血气分析,红细胞压积试验,血沉及普通生化测定等。

7.血浆分离管(浅绿色头盖),在惰性分离胶管内加入肝素抗凝剂,可达到快速分离血浆的目的,是电解质检测的最佳选择,也可用于常规血浆生化测定和ICU等急诊血浆生化检测。血浆标本在冷藏状态下保持48小时内稳定。

8.草酸钾/氟化钠的采血管(灰色头盖),氟化钠是一种弱效抗凝剂,一般常同草酸钾合并使用,其比例为氟化钠1份,草酸钾3份。此混合物4mg可使1ml血液在23天内不凝固和抑制糖分解,是血糖测定的优良保存剂,使用时应注意缓慢颠倒混匀。注意它不能用于尿素酶法测定尿素,也不能用于检测碱性磷酸酶和淀粉酶。

9.EDTA抗凝管(紫色头盖),采血管内含有乙二胺四乙酸(EDTA)盐,可以有效地螯合血液标本中钙离子,螯合钙或将钙反应位点移去,阻滞和终止内源性或外源性凝过程,从而防止血液标本凝固。离心后,上层血浆主要适用于一般血液学检验,比如血浆中同型半胱氨酸、腺苷同型半胱氨酸、腺苷甲硫氨酸水平等,不适用于凝血试验及血小板功能检查。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=105855, encodeId=e5211058556d, content=这篇资讯带给我们新知识,启发新思维,不论是科研还是临床工作都有很大的帮助。。。, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzUn81b5CF5ibVPib8jWI92iciaxmqGHlwruOnK4SVZykd4iahqo1hicklIibyZoxm55X7EM8BW9eX1h1hQ2/0, createdBy=8aa81937526, createdName=李东泽, createdTime=Sat Aug 27 22:07:00 CST 2016, time=2016-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=67546, encodeId=421f6e54610, content=还真得好好学习一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d331664955, createdName=老段, createdTime=Sun Mar 06 10:14:00 CST 2016, time=2016-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1362031, encodeId=393d1362031f5, content=<a href='/topic/show?id=b3d195659ce' target=_blank style='color:#2F92EE;'>#采血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95659, encryptionId=b3d195659ce, topicName=采血)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6c3a189, createdName=longqijun248, createdTime=Sun Mar 06 02:07:00 CST 2016, time=2016-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=67398, encodeId=ad346e39892, content=不错,学习了。, beContent=null, objectType=article, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRup3ZySN7pRumibhPI2BoiaQhKq1nNw12XV6fialRdJCf2SibHI6STP24k3xKprg64xq7krHibhHWfTwe/0, createdBy=283f1318137, createdName=上官海棠, createdTime=Sat Mar 05 19:07:00 CST 2016, time=2016-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=67395, encodeId=f7826e395d7, content=不错,有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7d571658461, createdName=大于菲菲, createdTime=Sat Mar 05 18:53:00 CST 2016, time=2016-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=67298, encodeId=ea536e298e0, content=好好学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sat Mar 05 10:21:00 CST 2016, time=2016-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=67167, encodeId=f8796e1670a, content=呀, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160219/IMG56C6C68249B6F6895.jpg, createdBy=4a1b1689144, createdName=tiffany8083, createdTime=Fri Mar 04 11:31:00 CST 2016, time=2016-03-04, status=1, ipAttribution=)]
    2016-08-27 李东泽

    这篇资讯带给我们新知识,启发新思维,不论是科研还是临床工作都有很大的帮助。。。

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=105855, encodeId=e5211058556d, content=这篇资讯带给我们新知识,启发新思维,不论是科研还是临床工作都有很大的帮助。。。, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzUn81b5CF5ibVPib8jWI92iciaxmqGHlwruOnK4SVZykd4iahqo1hicklIibyZoxm55X7EM8BW9eX1h1hQ2/0, createdBy=8aa81937526, createdName=李东泽, createdTime=Sat Aug 27 22:07:00 CST 2016, time=2016-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=67546, encodeId=421f6e54610, content=还真得好好学习一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d331664955, createdName=老段, createdTime=Sun Mar 06 10:14:00 CST 2016, time=2016-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1362031, encodeId=393d1362031f5, content=<a href='/topic/show?id=b3d195659ce' target=_blank style='color:#2F92EE;'>#采血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95659, encryptionId=b3d195659ce, topicName=采血)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6c3a189, createdName=longqijun248, createdTime=Sun Mar 06 02:07:00 CST 2016, time=2016-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=67398, encodeId=ad346e39892, content=不错,学习了。, beContent=null, objectType=article, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRup3ZySN7pRumibhPI2BoiaQhKq1nNw12XV6fialRdJCf2SibHI6STP24k3xKprg64xq7krHibhHWfTwe/0, createdBy=283f1318137, createdName=上官海棠, createdTime=Sat Mar 05 19:07:00 CST 2016, time=2016-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=67395, encodeId=f7826e395d7, content=不错,有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7d571658461, createdName=大于菲菲, createdTime=Sat Mar 05 18:53:00 CST 2016, time=2016-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=67298, encodeId=ea536e298e0, content=好好学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sat Mar 05 10:21:00 CST 2016, time=2016-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=67167, encodeId=f8796e1670a, content=呀, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160219/IMG56C6C68249B6F6895.jpg, createdBy=4a1b1689144, createdName=tiffany8083, createdTime=Fri Mar 04 11:31:00 CST 2016, time=2016-03-04, status=1, ipAttribution=)]
    2016-03-06 老段

    还真得好好学习一下

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=105855, encodeId=e5211058556d, content=这篇资讯带给我们新知识,启发新思维,不论是科研还是临床工作都有很大的帮助。。。, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzUn81b5CF5ibVPib8jWI92iciaxmqGHlwruOnK4SVZykd4iahqo1hicklIibyZoxm55X7EM8BW9eX1h1hQ2/0, createdBy=8aa81937526, createdName=李东泽, createdTime=Sat Aug 27 22:07:00 CST 2016, time=2016-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=67546, encodeId=421f6e54610, content=还真得好好学习一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d331664955, createdName=老段, createdTime=Sun Mar 06 10:14:00 CST 2016, time=2016-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1362031, encodeId=393d1362031f5, content=<a href='/topic/show?id=b3d195659ce' target=_blank style='color:#2F92EE;'>#采血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95659, encryptionId=b3d195659ce, topicName=采血)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6c3a189, createdName=longqijun248, createdTime=Sun Mar 06 02:07:00 CST 2016, time=2016-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=67398, encodeId=ad346e39892, content=不错,学习了。, beContent=null, objectType=article, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRup3ZySN7pRumibhPI2BoiaQhKq1nNw12XV6fialRdJCf2SibHI6STP24k3xKprg64xq7krHibhHWfTwe/0, createdBy=283f1318137, createdName=上官海棠, createdTime=Sat Mar 05 19:07:00 CST 2016, time=2016-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=67395, encodeId=f7826e395d7, content=不错,有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7d571658461, createdName=大于菲菲, createdTime=Sat Mar 05 18:53:00 CST 2016, time=2016-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=67298, encodeId=ea536e298e0, content=好好学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sat Mar 05 10:21:00 CST 2016, time=2016-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=67167, encodeId=f8796e1670a, content=呀, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160219/IMG56C6C68249B6F6895.jpg, createdBy=4a1b1689144, createdName=tiffany8083, createdTime=Fri Mar 04 11:31:00 CST 2016, time=2016-03-04, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=105855, encodeId=e5211058556d, content=这篇资讯带给我们新知识,启发新思维,不论是科研还是临床工作都有很大的帮助。。。, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzUn81b5CF5ibVPib8jWI92iciaxmqGHlwruOnK4SVZykd4iahqo1hicklIibyZoxm55X7EM8BW9eX1h1hQ2/0, createdBy=8aa81937526, createdName=李东泽, createdTime=Sat Aug 27 22:07:00 CST 2016, time=2016-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=67546, encodeId=421f6e54610, content=还真得好好学习一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d331664955, createdName=老段, createdTime=Sun Mar 06 10:14:00 CST 2016, time=2016-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1362031, encodeId=393d1362031f5, content=<a href='/topic/show?id=b3d195659ce' target=_blank style='color:#2F92EE;'>#采血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95659, encryptionId=b3d195659ce, topicName=采血)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6c3a189, createdName=longqijun248, createdTime=Sun Mar 06 02:07:00 CST 2016, time=2016-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=67398, encodeId=ad346e39892, content=不错,学习了。, beContent=null, objectType=article, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRup3ZySN7pRumibhPI2BoiaQhKq1nNw12XV6fialRdJCf2SibHI6STP24k3xKprg64xq7krHibhHWfTwe/0, createdBy=283f1318137, createdName=上官海棠, createdTime=Sat Mar 05 19:07:00 CST 2016, time=2016-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=67395, encodeId=f7826e395d7, content=不错,有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7d571658461, createdName=大于菲菲, createdTime=Sat Mar 05 18:53:00 CST 2016, time=2016-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=67298, encodeId=ea536e298e0, content=好好学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sat Mar 05 10:21:00 CST 2016, time=2016-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=67167, encodeId=f8796e1670a, content=呀, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160219/IMG56C6C68249B6F6895.jpg, createdBy=4a1b1689144, createdName=tiffany8083, createdTime=Fri Mar 04 11:31:00 CST 2016, time=2016-03-04, status=1, ipAttribution=)]
    2016-03-05 上官海棠

    不错,学习了。

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=105855, encodeId=e5211058556d, content=这篇资讯带给我们新知识,启发新思维,不论是科研还是临床工作都有很大的帮助。。。, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzUn81b5CF5ibVPib8jWI92iciaxmqGHlwruOnK4SVZykd4iahqo1hicklIibyZoxm55X7EM8BW9eX1h1hQ2/0, createdBy=8aa81937526, createdName=李东泽, createdTime=Sat Aug 27 22:07:00 CST 2016, time=2016-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=67546, encodeId=421f6e54610, content=还真得好好学习一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d331664955, createdName=老段, createdTime=Sun Mar 06 10:14:00 CST 2016, time=2016-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1362031, encodeId=393d1362031f5, content=<a href='/topic/show?id=b3d195659ce' target=_blank style='color:#2F92EE;'>#采血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95659, encryptionId=b3d195659ce, topicName=采血)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6c3a189, createdName=longqijun248, createdTime=Sun Mar 06 02:07:00 CST 2016, time=2016-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=67398, encodeId=ad346e39892, content=不错,学习了。, beContent=null, objectType=article, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRup3ZySN7pRumibhPI2BoiaQhKq1nNw12XV6fialRdJCf2SibHI6STP24k3xKprg64xq7krHibhHWfTwe/0, createdBy=283f1318137, createdName=上官海棠, createdTime=Sat Mar 05 19:07:00 CST 2016, time=2016-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=67395, encodeId=f7826e395d7, content=不错,有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7d571658461, createdName=大于菲菲, createdTime=Sat Mar 05 18:53:00 CST 2016, time=2016-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=67298, encodeId=ea536e298e0, content=好好学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sat Mar 05 10:21:00 CST 2016, time=2016-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=67167, encodeId=f8796e1670a, content=呀, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160219/IMG56C6C68249B6F6895.jpg, createdBy=4a1b1689144, createdName=tiffany8083, createdTime=Fri Mar 04 11:31:00 CST 2016, time=2016-03-04, status=1, ipAttribution=)]
    2016-03-05 大于菲菲

    不错,有用

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=105855, encodeId=e5211058556d, content=这篇资讯带给我们新知识,启发新思维,不论是科研还是临床工作都有很大的帮助。。。, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzUn81b5CF5ibVPib8jWI92iciaxmqGHlwruOnK4SVZykd4iahqo1hicklIibyZoxm55X7EM8BW9eX1h1hQ2/0, createdBy=8aa81937526, createdName=李东泽, createdTime=Sat Aug 27 22:07:00 CST 2016, time=2016-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=67546, encodeId=421f6e54610, content=还真得好好学习一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d331664955, createdName=老段, createdTime=Sun Mar 06 10:14:00 CST 2016, time=2016-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1362031, encodeId=393d1362031f5, content=<a href='/topic/show?id=b3d195659ce' target=_blank style='color:#2F92EE;'>#采血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95659, encryptionId=b3d195659ce, topicName=采血)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6c3a189, createdName=longqijun248, createdTime=Sun Mar 06 02:07:00 CST 2016, time=2016-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=67398, encodeId=ad346e39892, content=不错,学习了。, beContent=null, objectType=article, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRup3ZySN7pRumibhPI2BoiaQhKq1nNw12XV6fialRdJCf2SibHI6STP24k3xKprg64xq7krHibhHWfTwe/0, createdBy=283f1318137, createdName=上官海棠, createdTime=Sat Mar 05 19:07:00 CST 2016, time=2016-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=67395, encodeId=f7826e395d7, content=不错,有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7d571658461, createdName=大于菲菲, createdTime=Sat Mar 05 18:53:00 CST 2016, time=2016-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=67298, encodeId=ea536e298e0, content=好好学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sat Mar 05 10:21:00 CST 2016, time=2016-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=67167, encodeId=f8796e1670a, content=呀, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160219/IMG56C6C68249B6F6895.jpg, createdBy=4a1b1689144, createdName=tiffany8083, createdTime=Fri Mar 04 11:31:00 CST 2016, time=2016-03-04, status=1, ipAttribution=)]
    2016-03-05 忠诚向上

    好好学习

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=105855, encodeId=e5211058556d, content=这篇资讯带给我们新知识,启发新思维,不论是科研还是临床工作都有很大的帮助。。。, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzUn81b5CF5ibVPib8jWI92iciaxmqGHlwruOnK4SVZykd4iahqo1hicklIibyZoxm55X7EM8BW9eX1h1hQ2/0, createdBy=8aa81937526, createdName=李东泽, createdTime=Sat Aug 27 22:07:00 CST 2016, time=2016-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=67546, encodeId=421f6e54610, content=还真得好好学习一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d331664955, createdName=老段, createdTime=Sun Mar 06 10:14:00 CST 2016, time=2016-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1362031, encodeId=393d1362031f5, content=<a href='/topic/show?id=b3d195659ce' target=_blank style='color:#2F92EE;'>#采血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95659, encryptionId=b3d195659ce, topicName=采血)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6c3a189, createdName=longqijun248, createdTime=Sun Mar 06 02:07:00 CST 2016, time=2016-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=67398, encodeId=ad346e39892, content=不错,学习了。, beContent=null, objectType=article, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRup3ZySN7pRumibhPI2BoiaQhKq1nNw12XV6fialRdJCf2SibHI6STP24k3xKprg64xq7krHibhHWfTwe/0, createdBy=283f1318137, createdName=上官海棠, createdTime=Sat Mar 05 19:07:00 CST 2016, time=2016-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=67395, encodeId=f7826e395d7, content=不错,有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7d571658461, createdName=大于菲菲, createdTime=Sat Mar 05 18:53:00 CST 2016, time=2016-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=67298, encodeId=ea536e298e0, content=好好学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sat Mar 05 10:21:00 CST 2016, time=2016-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=67167, encodeId=f8796e1670a, content=呀, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160219/IMG56C6C68249B6F6895.jpg, createdBy=4a1b1689144, createdName=tiffany8083, createdTime=Fri Mar 04 11:31:00 CST 2016, time=2016-03-04, status=1, ipAttribution=)]
    2016-03-04 tiffany8083

    0